Edition:
India

GW Pharmaceuticals PLC (GWPH.OQ)

GWPH.OQ on NASDAQ Stock Exchange Global Market

150.17USD
19 Feb 2019
Change (% chg)

-- (--)
Prev Close
$150.17
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
134,712
52-wk High
$179.65
52-wk Low
$90.20

Chart for

About

GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers... (more)

Overall

Beta: 2.68
Market Cap(Mil.): $2,789.42
Shares Outstanding(Mil.): 2.11
Dividend: --
Yield (%): --

Financials

GW Pharma cannabis drug set to hit market following DEA nod

U.S.-listed shares of GW Pharmaceuticals rose 8 percent on Thursday as its marijuana-based treatment Epidiolex cleared the last hurdle after the Drug Enforcement Administration labeled the drug as having a low abuse potential.

27 Sep 2018

Earnings vs. Estimates